Aviwell Closes €11 Million Series A Investment Round to Scale AI‑Driven Microbiota Platform for Sustainable Animal Nutrition
23.1.2026 06:01:00 CET | ACCESS Newswire | Press Release
TOULOUSE, FRANCE AND BOSTON, MA / ACCESS Newswire / January 23, 2026 / Aviwell SAS, a deep‑tech animal nutrition company headquartered in Toulouse, today announced the successful completion of a €11 million Series A investment round, welcoming three new investors: Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners. The financing will support Aviwell's next phase of growth as the company scales its AI‑driven microbiome discovery and development platform and advances native, nature‑based biological solutions for global agri‑food markets, initially focused on poultry and aquaculture.
Built on decades of research pioneered by Aviwell's co‑Founder, Prof. Remy BURCELIN, into how naturally occurring bacterial ecologies administered early in life can have a durable impact on animal growth, health, and resilience, Aviwell has developed Aneto™, an AI‑powered microbiome discovery platform.
Aneto™ identifies specific molecular mechanisms - modes of action - that enable the selection of native bacterial communities to create tailored bacterial ecologies designed to enhance animal performance, immunity, and robustness. This approach delivers a highly efficient discovery process, reducing research and development timelines and costs while accelerating time to market.
By combining advanced microbiota analysis with AI and machine‑learning‑driven discovery, Aviwell delivers measurable improvements in feed efficiency and immune function support while significantly lowering the cost and complexity of developing next‑generation animal nutrition solutions.
Aviwell will use the newly raised capital to advance its poultry and aquaculture microbial ecologies from discovery through validation and scale‑up. The company will also expand Aneto™ platform services, strengthen discovery and demonstration capabilities, and deepen commercial engagement with partners and customers.
"Aviwell sits at the intersection of two powerful market forces: rising global demand for animal protein, and the accelerating consumer shift toward natural, sustainable, antibiotic‑free production systems," explained Mouli RAMANI, the President and CEO of Aviwell. "With Aneto™, we can translate microbiome complexity into practical, scalable solutions-helping livestock and aquaculture producers improve productivity while reducing their environmental footprint. With the support of our new investors, Aviwell will accelerate development in poultry and aquaculture and expand our platform and product pipeline."
The financing round was led by Blue Revolution Fund (BRF), which invests globally in sustainable aquaculture, alternative seafood, and nutrition solutions. Georg BAUNACH, Managing Partner at BRF, stated: "We are deeply impressed by Aviwell's scientific depth and technological precision. Aneto™ represents a new generation of microbiome innovation-one that captures the inherent complexity of biological systems. We believe this approach can unlock the next wave of solutions for poultry, aquaculture and livestock in general by delivering meaningful improvements in performance, resilience and environmental footprint."
Blast Club also joins the round, reinforcing its commitment to innovative agri‑food technologies through equity crowdfunding. "We invested in Aviwell for one simple reason: they are revolutionizing the agri‑food industry. Aviwell uses AI and life sciences to naturally boost animal growth, without hormones or antibiotics, simply by working on the microbiota," shared Anthony BOURBON, founder of Blast.Club. "That's what we like: impact, innovation and a real long‑term vision. Feeding better, in a healthier, more sustainable way. Changing the rules of the game instead of playing by them."
The third new investor, SWEN Capital Partners, is a Paris‑based responsible investment firm active across private equity, infrastructure, private debt, and direct impact strategies. "Investing in the microbiome means investing in the future of health and a sustainable economy. For us, supporting Aviwell is about building a measurable, sustainable economic model - reducing chronic disease costs and creating responsible, long-term value," said Julien BOURRET, Investment Director at SWEN CP.
The three new investors join Aviwell's existing investors, including Elaia and MFS Investment Management, who also participated in the round.
With this Series A financing, Aviwell is positioned to accelerate the translation of cutting-edge microbiome science into scalable, nature-based solutions for animal nutrition. By advancing its AI-driven Aneto™ platform and expanding commercial collaborations, the company aims to support more resilient, efficient, and sustainable protein production systems worldwide.
About Aviwell
Founded in France, Aviwell is a deep-tech animal nutrition company developing next-generation, microbiome-based solutions to improve animal health, performance, and robustness. Leveraging its proprietary Aneto™ AI-driven discovery platform, Aviwell designs native bacterial ecologies with defined modes of action to support productivity while reducing reliance on antibiotics. The company initially focuses on poultry and aquaculture, addressing key sustainability challenges in global agri-food systems. www.aviwell.fr
About BRF:
The Blue Revolution Fund (BRF) is a €92M global venture capital vehicle, managed by Hatch Blue, focused on scaling the aquaculture industry through sustainable innovation. Hatch Blue is a specialist asset manager and professional services firm that leverages three strategic pillars - Investment (Hatch Funds I/II and BRF), Consulting, and Programs - to catalyze growth across the global blue economy. Learn more at BRF Hatch Blue
About Blast.Club
Founded in 2023 by Anthony Bourbon and Samuel Guez, Blast is a private investment club that invested €125 million in 2025. With a team of over 60 employees, Blast focuses in particular on new technologies (Deeptech, AI, Biotech, Medtech, etc.) The investment club now brings together more than 14,000 engaged members, offering a strong and dynamic network for investors and entrepreneurs. More information at blast.club
About SWEN Capital Partners:
SWEN Capital Partners is a key player in sustainable investment across private equity, infrastructure, and mezzanine debt, with over €10 billion* in assets under management and advisory, and more than 120 employees. The management company is part of the Ofi Invest Group - whose main shareholders are entities of the Aéma Group (Macif, Abeille Assurances Holding, Aésio Mutuelle) - and SWEN Managers, a holding company owned by around 50 employees. From the outset, SWEN has placed sustainable finance at the core of its strategy, offering clients innovative and responsible investment solutions. In February 2024, SWEN CP became a Mission driven company, marking a decisive commitment to serving Nature. * Cumulative commitments as of September 1, 2025
Learn more at swen-cp.com
Media Contacts
Aviwell SAS
David GILBERT, VP Business Development
david@aviwell.fr
Blue Revolution Fund
Sol PARK, Principal
sol@hatch.blue
Blast.Club
Emilie BAUER, Head of Communication
eb@blast.club - 06 75 19 42 81
SWEN CP
Lola FORNARI
LFORNARI@swen-cp.fr
End of Release
SOURCE: Aviwell USA
View the original press release on ACCESS Newswire
Aviwell USA

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Ore Energy Completes EU-Funded Multi-Day Energy Storage Pilot At EDF R&D Laboratories In France10.2.2026 09:00:00 CET | Press Release
100-Hour Iron-Air Long-Duration Energy Storage (LDES) System Piloted Under The European Union's "StoRIES" Programme AMSTERDAM, NL / ACCESS Newswire / February 10, 2026 / Ore Energy, the Netherlands-based iron-air long-duration energy storage startup, today announced the successful completion of a grid-connected technical pilot of its 100-hour iron-air energy storage system at EDF Lab les Renardières in Écuelles, France, as part of the European Union's Storage Research Infrastructure Eco-System ("StoRIES") programme. The pilot - among the first of its kind in Europe - demonstrated that the company's iron-air LDES technology is able to deliver multi-day energy storage in a real-world utility environment. As part of the StoRIES-supported pilot, Ore Energy deployed its modular iron-air battery system to collect operational data under real-world grid conditions and demonstrated that it can store and discharge energy for up to roughly four days (100 hours). Over several months, the system wa
RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio9.2.2026 23:00:00 CET | Press Release
All amounts in US dollars unless otherwise stated. VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF)(FSE:Y2V) ("RE Royalties" or the "Company") is pleased to announce a further USD $800,000 investment toward the purchase of royalties on two portfolios of distributed generation ("DG") solar projects located throughout the United States being developed by Solaris Energy Inc. ("Solaris"). The Royalty Purchase for Portfolio 1 totals USD $4.8 million, of which USD $3 million was funded at closing, as announced on January 7, 2026. The Company expects to fund the remaining USD $1 million by Q2 2026, subject to the satisfaction of applicable conditions. The Royalty Purchase for Portfolio 2 is subject to the completion of due diligence to the satisfaction of the Company, other customary closing conditions, and is expected to occur later in the year, bringing the total portfolio level royalty investment to USD $9 million. The Royalty Rate will be adju
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press Release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press Release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press Release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom